Beacon Securities reiterated their buy rating on shares of Burcon NutraScience (TSE:BU) (NYSE:BUR) in a report published on Monday morning, Zacks.com reports. Beacon Securities also issued estimates for Burcon NutraScience’s FY2020 earnings at ($0.06) EPS, FY2021 earnings at ($0.03) EPS and FY2022 earnings at $0.07 EPS.
Burcon NutraScience stock opened at C$0.80 on Monday. The company has a 50 day moving average of C$0.76. The stock has a market cap of $47.92 million and a P/E ratio of -7.34. Burcon NutraScience has a 1 year low of C$0.13 and a 1 year high of C$1.87. The company has a quick ratio of 0.14, a current ratio of 0.21 and a debt-to-equity ratio of 650.26.
In related news, Director Johann Franz Tergesen purchased 56,000 shares of Burcon NutraScience stock in a transaction dated Thursday, July 4th. The shares were acquired at an average cost of C$0.68 per share, with a total value of C$37,800.00. Following the purchase, the director now owns 1,066,169 shares of the company’s stock, valued at C$719,664.08. Insiders bought a total of 163,000 shares of company stock worth $90,530 over the last three months.
Burcon NutraScience Corporation, together with its subsidiary, develops plant protein extraction and purification technology of functional and renewable plant proteins in Canada. Its products include CLARISOY, a soy protein for dairy foods, neutral pH beverages, and coffee creamers/whiteners; and Peazazz, a novel pea protein isolate.
Further Reading: How are Outstanding Shares Different from Authorized Shares?
Receive News & Ratings for Burcon NutraScience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Burcon NutraScience and related companies with MarketBeat.com's FREE daily email newsletter.